ROCKET-AF With Rivaroxaban Enrolls High-Risk Patients

Patients with atrial fibrillation enrolled in the ROCKET-AF trial--looking at whether the novel anticoagulant rivaroxaban is better than warfarin for preventing stroke--are at higher risk of stroke than those who have participated in other recent trials of novel agents for this indication. Heartwire

More on Sciencestage.com

    More on Wikipedia

      Related Videos

      • ROCKET AF trial suggests that digoxin increases risk of death in AF patients
        ROCKET AF trial suggests that digoxin increases risk of death in AF patients ROCKET AF trial suggests that digoxin increases risk of death in AF patients. From: Op9021jsd Views: 11 0 ratings Time: 02:07 More in People & Blogs
      • ROCKET AF (Part II): Video Interview with Jonathan Halperin, MD, FAHA
        ROCKET AF (Part II): Video Interview with Jonathan Halperin, MD, FAHA Science News video interview from Scientific Sessions 2010. Trial: ROCKET-AF - Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with Warfarin in Patients... From: AHAScienceNews Views: 1058 3 ratings Time: 03:33 More in Science & Technology
      • ROCKET AF (Part I): Video Interview with Manesh Patel
        ROCKET AF (Part I): Video Interview with Manesh Patel Science News video interview from Scientific Sessions2010 Trial: ROCKET AF - Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with Warfarin in Patients with... From: AHAScienceNews Views: 1723 2 ratings Time: 03:16 More in Science & Technology

      More on answers.yahoo.com

        More on Pubmed

          More on Answers.com